BRKD

Direxion Daily BRKB Bear 1X Shares

$22.75
+0.00%
Market closed. Last update: 10:50 PM ET

📎 Investment Objective

The Direxion Daily BRKB Bear 1X Shares ETF (BRKD) seeks to provide daily investment results that correspond to the inverse (-1x) of the daily performance of the Class B shares of Berkshire Hathaway Inc. (BRKB).

Overview

ETF tracking Direxion Daily BRKB Bear 1X Shares

Category Inverse
Issuer Other
Inception Date 2024-12-11
Market Cap $2.8M
Average Volume N/A
Dividend Yield 3.03%
52-Week Range $21.32 - $26.28
VWAP $22.75

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The Direxion Daily BRKB Bear 1X Shares ETF (BRKD) seeks to provide daily investment results that correspond to the inverse (-1x) of the daily performance of the Class B shares of Berkshire Hathaway Inc. (BRKB).

🎯 Investment Strategy

The fund uses a range of financial instruments, such as swap agreements and futures contracts, to gain the desired inverse exposure to the BRKB stock. It does not actually hold the underlying BRKB shares.

✨ Key Features

  • Provides -1x daily inverse exposure to the Class B shares of Berkshire Hathaway Inc.
  • Designed for short-term, tactical trading rather than long-term buy-and-hold investing.
  • Employs derivatives to achieve its inverse performance objective.
  • Has a very low expense ratio of 0.00%

⚠️ Primary Risks

  • Inverse/leveraged risk: The fund's inverse exposure means it will lose value when the underlying asset gains, potentially at an accelerated rate.
  • Volatility risk: The fund's returns can be highly volatile due to its use of derivatives and inverse exposure.
  • Tracking error risk: The fund may not perfectly track the inverse performance of BRKB on a daily basis.
  • Liquidity risk: The fund may have limited liquidity, especially during periods of market stress.

👤 Best For

This ETF is designed for experienced, sophisticated investors who understand the risks of inverse/leveraged products and are seeking short-term, tactical exposure to the inverse performance of Berkshire Hathaway Class B shares. It is not suitable for long-term buy-and-hold investors or those with a low risk tolerance.